KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Operating Expenses: 2011-2024

Historic Operating Expenses for Sarepta Therapeutics (SRPT) over the last 14 years, with Dec 2024 value amounting to $1.7 billion.

  • Sarepta Therapeutics' Operating Expenses rose 187.44% to $1.0 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $2.6 billion, marking a year-over-year increase of 76.34%. This contributed to the annual value of $1.7 billion for FY2024, which is 11.43% up from last year.
  • Sarepta Therapeutics' Operating Expenses amounted to $1.7 billion in FY2024, which was up 11.43% from $1.5 billion recorded in FY2023.
  • In the past 5 years, Sarepta Therapeutics' Operating Expenses ranged from a high of $1.7 billion in FY2024 and a low of $1.1 billion during FY2020.
  • Over the past 3 years, Sarepta Therapeutics' median Operating Expenses value was $1.5 billion (recorded in 2023), while the average stood at $1.6 billion.
  • Data for Sarepta Therapeutics' Operating Expenses shows a peak YoY climbed of 26.48% (in 2022) over the last 5 years.
  • Over the past 5 years, Sarepta Therapeutics' Operating Expenses (Yearly) stood at $1.1 billion in 2020, then climbed by 5.19% to $1.2 billion in 2021, then rose by 26.48% to $1.5 billion in 2022, then increased by 2.85% to $1.5 billion in 2023, then climbed by 11.43% to $1.7 billion in 2024.